AK Medical repurchases 1.09 million shares for HKD 6.25 million, lifting cumulative buy-backs to 11.19% of mandate base

Bulletin Express

06/03

AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices ranging from HKD 5.70 to HKD 5.75 per share, resulting in a total consideration of HKD 6.25 million.

Including the latest purchase, AK Medical has bought back 12.56 million shares since the current mandate was approved on 18 June 2025. This volume represents 11.19% of the company’s issued share capital on the mandate’s reference date.

All repurchased shares—1.09 million on 3 June 2026 and 11.47 million from earlier trades—remain pending cancellation. Consequently, the issued share capital is unchanged at 1.12 billion shares as at 3 June 2026.

Under Main Board Rule 10.06(3), AK Medical is restricted from issuing new shares until 3 July 2026, 30 days after the latest buy-back. Ma Rongkun, Company Secretary, confirmed that the transactions complied with all applicable listing rules and regulatory requirements.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1174436460"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1174436460\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1174436460?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 21:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1174436460","market":"us","top_or_hot":-1,"title":"AK Medical repurchases 1.09 million shares for HKD 6.25 million, lifting cumulative buy-backs to 11.19% of mandate base","media":"Bulletin Express","content":"<p>AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices ranging from HKD 5.70 to HKD 5.75 per share, resulting in a total consideration of HKD 6.25 million.</p>\n<p>Including the latest purchase, AK Medical has bought back 12.56 million shares since the current mandate was approved on 18 June 2025. This volume represents 11.19% of the company’s issued share capital on the mandate’s reference date.</p>\n<p>All repurchased shares—1.09 million on 3 June 2026 and 11.47 million from earlier trades—remain pending cancellation. Consequently, the issued share capital is unchanged at 1.12 billion shares as at 3 June 2026.</p>\n<p>Under Main Board Rule 10.06(3), AK Medical is restricted from issuing new shares until 3 July 2026, 30 days after the latest buy-back. Ma Rongkun, Company Secretary, confirmed that the transactions complied with all applicable listing rules and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AK Medical repurchases 1.09 million shares for HKD 6.25 million, lifting cumulative buy-backs to 11.19% of mandate base</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAK Medical repurchases 1.09 million shares for HKD 6.25 million, lifting cumulative buy-backs to 11.19% of mandate base\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-06-03 21:05</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices ranging from HKD 5.70 to HKD 5.75 per share, resulting in a total consideration of HKD 6.25 million.</p>\n<p>Including the latest purchase, AK Medical has bought back 12.56 million shares since the current mandate was approved on 18 June 2025. This volume represents 11.19% of the company’s issued share capital on the mandate’s reference date.</p>\n<p>All repurchased shares—1.09 million on 3 June 2026 and 11.47 million from earlier trades—remain pending cancellation. Consequently, the issued share capital is unchanged at 1.12 billion shares as at 3 June 2026.</p>\n<p>Under Main Board Rule 10.06(3), AK Medical is restricted from issuing new shares until 3 July 2026, 30 days after the latest buy-back. Ma Rongkun, Company Secretary, confirmed that the transactions complied with all applicable listing rules and regulatory requirements.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01789","symbol_name":"愛康醫療","start_time":0,"source_url":"","article_id":"1174436460","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1174436460","pubTimestamp":1780491912,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01789":"爱康医疗"},"translate_title":"爱康医疗625万港元回购109万股累计回购升至授权基数11.19%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01789":1},"content_text":"AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices ranging from HKD 5.70 to HKD 5.75 per share, resulting in a total consideration of HKD 6.25 million.\nIncluding the latest purchase, AK Medical has bought back 12.56 million shares since the current mandate was approved on 18 June 2025. This volume represents 11.19% of the company’s issued share capital on the mandate’s reference date.\nAll repurchased shares—1.09 million on 3 June 2026 and 11.47 million from earlier trades—remain pending cancellation. Consequently, the issued share capital is unchanged at 1.12 billion shares as at 3 June 2026.\nUnder Main Board Rule 10.06(3), AK Medical is restricted from issuing new shares until 3 July 2026, 30 days after the latest buy-back. Ma Rongkun, Company Secretary, confirmed that the transactions complied with all applicable listing rules and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}